论文信息 - Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion. - 字舞流文

Final results of the EORTC Brain Tumor Group randomized phase II TAVAREC trial on temozolomide with or without bevacizumab in 1st recurrence grade II/III glioma without 1p/19q co-deletion.

M. Taphoorn | T. Gorlia | J. Reijneveld | W. Wick | A. Idbaih | M. Smits | P. French | J. Kros | M. Klein | V. Golfinopoulos | M. Bent | P. Clement | F. Vos | P. Mulholland | T. Verschuere | Joanne Lewis | Iris de Heer